AbbVie Inc.
GB ˙ LSE ˙ US00287Y1091
218,50 $ ↑6,00 (2,82%)
2026-06-03
DEL PRIS
SecurityGB:0QCV / AbbVie Inc.
InstitutionRiverview Trust Co
Latest Disclosed Ownership3,193 shares
Latest Disclosed Value $ 694,446
Riverview Trust Co ownership in 0QCV / AbbVie Inc.

On May 1, 2026 - Riverview Trust Co filed a 13F-HR form disclosing ownership of 3,193 shares of AbbVie Inc. (GB:0QCV) valued at $691,348 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 3,193 shares of AbbVie Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $697,670 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F AbbVie Com 00287Y109 3,193 0 0.00 694 -4.80 0.6025
2026-01-26 2025-12-31 13F AbbVie Com 00287Y109 3,193 0 0.00 730 -1.35 0.8784
2025-10-22 2025-09-30 13F AbbVie Com 00287Y109 3,193 0 0.00 739 24.83 0.8932
2025-07-21 2025-06-30 13F AbbVie Com 00287Y109 3,193 -3,013 -48.55 593 -54.46 0.7376
2025-04-11 2025-03-31 13F AbbVie Com 00287Y109 6,206 -1,093 -14.97 1,300 0.23 1.2833
2025-02-06 2024-12-31 13F AbbVie Com 00287Y109 7,299 -45 -0.61 1,297 -10.55 1.1793
2024-10-18 2024-09-30 13F AbbVie Com 00287Y109 7,344 30 0.41 1,450 15.63 1.2720
2024-07-16 2024-06-30 13F AbbVie Com 00287Y109 7,314 -360 -4.69 1,254 -10.24 1.1890
2024-04-12 2024-03-31 13F AbbVie Com 00287Y109 7,674 0 0.00 1,397 17.49 1.0772
2024-01-24 2023-12-31 13F AbbVie Com 00287Y109 7,674 39 0.51 1,189 4.48 1.2101
2023-10-17 2023-09-30 13F AbbVie Com 00287Y109 7,635 0 0.00 1,138 10.70 1.0090
2023-07-18 2023-06-30 13F AbbVie Com 00287Y109 7,635 -180 -2.30 1,029 -17.43 0.9323
2023-04-20 2023-03-31 13F AbbVie Com 00287Y109 7,815 0 0.00 1,245 124,400.00 1.1448
2023-01-26 2022-12-31 13F AbbVie Com 00287Y109 7,815 -183 -2.29 1 -99.91 1.1950
2022-10-27 2022-09-30 13F AbbVie Com 00287Y109 7,998 -189 -2.31 1,073 -14.43 1.0386
2022-07-27 2022-06-30 13F AbbVie Com 00287Y109 8,187 249 3.14 1,254 -2.56 1.0929
2022-04-21 2022-03-31 13F AbbVie Com 00287Y109 7,938 786 10.99 1,287 32.95 0.9545
2022-01-19 2021-12-31 13F AbbVie Com 00287Y109 7,152 726 11.30 968 39.68 0.5679
2021-10-14 2021-09-30 13F AbbVie Com 00287Y109 6,426 756 13.33 693 8.45 0.7333
2021-07-16 2021-06-30 13F AbbVie Com 00287Y109 5,670 -320 -5.34 639 -1.39 0.6754
2021-04-19 2021-03-31 13F AbbVie Com 00287Y109 5,990 0 0.00 648 0.93 0.7228
2021-01-22 2020-12-31 13F AbbVie Com 00287Y109 5,990 -125 -2.04 642 19.78 0.7098
2020-10-15 2020-09-30 13F AbbVie Com 00287Y109 6,115 -45 -0.73 536 -11.40 0.6161
2020-07-08 2020-06-30 13F AbbVie Com 00287Y109 6,160 -320 -4.94 605 22.47 0.5868
2020-04-15 2020-03-31 13F/A-1 AbbVie Com 00287Y109 6,480 -3,700 -36.35 494 -45.23 0.4745
2020-04-15 2020-03-31 13F AbbVie Com 00287Y109 10,180 0 902 481,230.9268
2020-01-10 2019-12-31 13F AbbVie Com 00287Y109 10,180 -583 -5.42 902 10.67 0.6069
2019-10-16 2019-09-30 13F AbbVie Com 00287Y109 10,763 -4,962 -31.55 815 -28.70 0.5676
2019-07-12 2019-06-30 13F AbbVie Com 00287Y109 15,725 -703 -4.28 1,143 -13.67 0.8029
2019-04-10 2019-03-31 13F AbbVie Com 00287Y109 16,428 36 0.22 1,324 -12.38 1.0008
2019-02-11 2018-12-31 13F AbbVie COM 00287Y109 16,392 16,392 1,511 1.1819
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.